Efficacy of rimegepant for the acute treatment of migraine based on triptan treatment experience: Pooled results from three phase 3 randomized clinical trials.

MLA

Lipton, Richard B., et al. “Efficacy of Rimegepant for the Acute Treatment of Migraine Based on Triptan Treatment Experience: Pooled Results from Three Phase 3 Randomized Clinical Trials.” Cephalalgia : An International Journal of Headache, vol. 43, no. 2, Feb. 2023, p. 3331024221141686. EBSCOhost, https://doi.org/10.1177/03331024221141686.

APA

Lipton, R. B., Blumenfeld, A., Jensen, C. M., Croop, R., Thiry, A., L’Italien, G., Morris, B. A., Coric, V., & Goadsby, P. J. (2023). Efficacy of rimegepant for the acute treatment of migraine based on triptan treatment experience: Pooled results from three phase 3 randomized clinical trials. Cephalalgia : An International Journal of Headache, 43(2), 3331024221141686. https://doi.org/10.1177/03331024221141686

Chicago

Lipton, Richard B, Andrew Blumenfeld, Christopher M Jensen, Robert Croop, Alexandra Thiry, Gilbert L’Italien, Beth A Morris, Vladimir Coric, and Peter J Goadsby. 2023. “Efficacy of Rimegepant for the Acute Treatment of Migraine Based on Triptan Treatment Experience: Pooled Results from Three Phase 3 Randomized Clinical Trials.” Cephalalgia : An International Journal of Headache 43 (2): 3331024221141686. doi:10.1177/03331024221141686.